Maccioni ́s group reported that LPS signaling via TLR4 on tumor cells in vitro triggers the secretion of IFN-γ by tumor-infiltrating lymphocytes, and the secretion of IFN-β by tumor cells, modifying tumor outgrowth in vivo [67, 81]. The gene discussed is IFNG; the disease is neoplasm.